Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 Trading Update

2 May 2007 07:00

Embargoed Release: 07:00hrs Wednesday 2nd May 2007

SOPHEON PLC ("Sopheon" or the "Company") TRADING UPDATE

Sopheon plc, the international provider of software and services that improve the financial return from innovation and product development investments issues a trading update. The first quarter of the year is traditionally quiet in the software business but we were pleased to record revenues 37% higher than in the first quarter of 2006. In addition to delivering license and service agreements secured in the prior year, we closed a further six license orders of which three were license extensions from existing customers. We also generated revenue from a number of new consultancy assignments. At the end of the first quarter, revenue visibility for the full year from contracted business and recurring revenue streams stood at ‚£3 million, added to which the potential of the sales pipeline remains very encouraging for the coming quarter and beyond. We would continue to emphasize that the timing and size of individual sales can cause variation in our reported results from period to period. Nevertheless, by the end of the first quarter 90 companies had licensed our software, and we expect this ongoing growth in the customer base to drive a rising pattern of repeat business, with continuing improvement in predictability over time.

In our 2006 preliminary statement we outlined our strategic priorities for the coming year. We are pleased to report progress on a range of fronts. As noted above, our customer base is delivering strong levels of repeat business. This is expected to continue, and is reinforced by an ongoing pattern of introducing our software into one or several business units within a large global company and expanding enterprise-wide over time. Customers signed in the first quarter all came from our target markets of chemicals, food and beverage, and consumer goods, as we deepen our market position in these segments. Our emerging relationship with Hewlett-Packard delivered a substantial services extension from the major auto customer we secured last year. Sopheon's initiative aimed at building productive partnerships with consulting firms continued to progress. New levels of interest and activity showed good promise of future sales as we furthered our work with strategic partners on a number of additional business opportunities. Some, like the auto customer, take us beyond traditional markets and territories.

Our product development team is continuing to move forward on its already well-advanced work on the next release of Accolade. At the same time, we are busily preparing for upcoming sessions of our European and North American Product Advisory Councils, which will convene in May. The council groups are comprised of executive-level decision-makers from some of the leading companies in the world, including BASF, Cadbury Schweppes, Campina, Celanese, Cytec, Electrolux, Hospira, Land O'Lakes, Nautilus, Nestle, Parker Hannifin, Verizon Wireless and Timex. A principal value of the impending meetings is that they will help us set market-driven priorities for the development of our Accolade product roadmap for 2008.

Over the last five years we have invested substantial resources in the development of our business, simultaneously driving for annual improvements in financial performance. This led to the achievement of positive EBITDA for the first time in 2006, making it a milestone year for Sopheon. We will continue to balance the needs of driving Sopheon forward strategically whilst staying focused on financial performance. We expect to maintain our established trend of advancement in 2007 and beyond.

For further information contact:

Barry Mence, Chairman Sopheon plc Tel: +44 (0) 1483 685735 Arif Karimjee, CFO Sarah Wharry, Seymour Pierce Limited Tel: +44 (0) 207 107 8000 Nominated Adviser Andrew Tan Hansard Group Tel: +44 (0) 207 245 1100 +44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel: +31 (0) 205 754 010About Sopheon

Sopheon is an international provider of software and services that help organizations improve the business impact of product innovation. The Sopheon Accolade‚® system automates gate or phase-based product development processes and provides strategic decision support that allows companies to increase revenue and profits from new products. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

SOPHEON PLC
Date   Source Headline
21st Feb 20247:00 amRNSCancellation - Sopheon Plc
20th Feb 20244:31 pmRNSScheme of Arrangement becomes Effective
20th Feb 20247:30 amRNSSuspension - Sopheon plc
16th Feb 20241:40 pmRNSIssue of Equity, PDMR Dealing and Rule 2.9
16th Feb 20241:35 pmRNSCourt Sanction of Scheme of Arrangement
16th Feb 20249:04 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
14th Feb 20248:32 amRNSForm 8.5 (EPT/NON-RI)
13th Feb 20245:30 pmRNSSopheon
9th Feb 20243:30 pmRNSForm 8.3 - SPHN LN
9th Feb 20249:35 amRNSForm 8.3 - Sopheon plc
9th Feb 20249:14 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20242:00 pmRNSResults of Court Meeting and General Meeting
17th Jan 20241:31 pmRNSHolding(s) in Company
17th Jan 20249:42 amRNSForm 8.3 - Sopheon plc
16th Jan 20245:45 pmRNSPublication of Scheme Document
15th Jan 202410:53 amRNSForm 8.3 - Sopheon plc
15th Jan 20248:13 amRNSForm 8.3 - SOPHEON PLC
12th Jan 20243:22 pmRNSForm 8.3 - Sopheon PLC
11th Jan 20248:50 amRNSSatisfaction of NSIA Condition
11th Jan 20248:49 amRNSForm 8.3 - SOPHEON PLC
10th Jan 20249:13 amRNSForm 8.3 - SOPHEON PLC
9th Jan 202412:35 pmRNSForm 8.3 - Sopheon plc
9th Jan 20248:48 amRNSForm 8.3 - SOPHEON PLC
8th Jan 202412:22 pmRNSIssue of Equity
8th Jan 20248:31 amRNSForm 8.3 - SOPHEON PLC
4th Jan 20249:45 amRNSForm 8.3 - SOPHEON PLC
2nd Jan 20245:18 pmRNSForm 8.3 - Sopheon Plc
2nd Jan 20249:07 amRNSForm 8.3 - SOPHEON PLC
22nd Dec 20231:00 pmRNSRecommended Cash Offer
15th Dec 20238:39 amRNSForm 8.5 (EPT/NON-RI)
13th Dec 20238:32 amRNSForm 8.5 (EPT/NON-RI)
12th Dec 202310:55 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20238:37 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202310:41 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20238:36 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 20239:16 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 20236:18 pmRNSRule 2.9 Announcement
4th Dec 202312:30 pmRNSIssue of Equity
28th Nov 20237:00 amRNSOffer update - extension to PUSU Deadline
17th Nov 202311:39 amRNSForm 8.5 (EPT/NON-RI)
15th Nov 20239:30 amRNSForm 8.5 (EPT/NON-RI)
14th Nov 20232:59 pmRNSForm 8.3 - SOPHEON PLC
10th Nov 202311:40 amRNSForm 8.5 (EPT/NON-RI)
10th Nov 202311:09 amRNSForm 8.3 - Rivomore Limited - Sopheon plc - Amend
9th Nov 20239:15 amRNSForm 8.5 (EPT/NON-RI)
8th Nov 202312:57 pmRNSForm 8.3 - Sopheon plc
8th Nov 202310:25 amRNSForm 8.5 (EPT/NON-RI) - Sopheon PLC
8th Nov 20237:00 amRNSForm 8 (OPD) Sopheon plc
7th Nov 202311:24 amRNSForm 8.5 (EPT/NON-RI)
6th Nov 20231:03 pmRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.